Apg Asset Management N.V. I Mab Transaction History

Apg Asset Management N.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$12.54 - $46.93 $63,565 - $237,888	-5,069 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$45.28 - $74.5 $22,640 - $37,250	500 Added 10.94%	5,069 $211,000
Q3 2021 Nov 15, 2021	BUY	$57.18 - $84.43 $66,843 - $98,698	1,169 Added 34.38%	4,569 $286,000
Q2 2021 Aug 13, 2021	BUY	$47.86 - $83.95 $162,724 - $285,430	3,400 New	3,400 $241,000

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.1M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.